These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 24440429)
1. Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology. Barker CI; Germovsek E; Hoare RL; Lestner JM; Lewis J; Standing JF Adv Drug Deliv Rev; 2014 Jun; 73(100):127-39. PubMed ID: 24440429 [TBL] [Abstract][Full Text] [Related]
2. The use of the SAEM algorithm in MONOLIX software for estimation of population pharmacokinetic-pharmacodynamic-viral dynamics parameters of maraviroc in asymptomatic HIV subjects. Chan PL; Jacqmin P; Lavielle M; McFadyen L; Weatherley B J Pharmacokinet Pharmacodyn; 2011 Feb; 38(1):41-61. PubMed ID: 21088872 [TBL] [Abstract][Full Text] [Related]
4. Antibiotic pharmacokinetic/pharmacodynamic modelling: MIC, pharmacodynamic indices and beyond. Rao GG; Landersdorfer CB Int J Antimicrob Agents; 2021 Aug; 58(2):106368. PubMed ID: 34058336 [TBL] [Abstract][Full Text] [Related]
5. Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling. Admiraal R; van Kesteren C; Boelens JJ; Bredius RG; Tibboel D; Knibbe CA Arch Dis Child; 2014 Mar; 99(3):267-72. PubMed ID: 24356807 [TBL] [Abstract][Full Text] [Related]
7. Development of a population pharmacokinetic-pharmacodynamic model of a single bolus dose of unfractionated heparin in paediatric patients. Al-Sallami H; Newall F; Monagle P; Ignjatovic V; Cranswick N; Duffull S Br J Clin Pharmacol; 2016 Jul; 82(1):178-84. PubMed ID: 26972703 [TBL] [Abstract][Full Text] [Related]
8. Model-Informed Drug Development for Anti-Infectives: State of the Art and Future. Rayner CR; Smith PF; Andes D; Andrews K; Derendorf H; Friberg LE; Hanna D; Lepak A; Mills E; Polasek TM; Roberts JA; Schuck V; Shelton MJ; Wesche D; Rowland-Yeo K Clin Pharmacol Ther; 2021 Apr; 109(4):867-891. PubMed ID: 33555032 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization. Nielsen EI; Cars O; Friberg LE Antimicrob Agents Chemother; 2011 Oct; 55(10):4619-30. PubMed ID: 21807983 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of antimicrobial drugs. Czock D; Markert C; Hartman B; Keller F Expert Opin Drug Metab Toxicol; 2009 May; 5(5):475-87. PubMed ID: 19416084 [TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetic and pharmacodynamic modelling in paediatric drug development with a focus on physiology-based pharmacokinetic simulations]. Läer S Z Evid Fortbild Qual Gesundhwes; 2019 May; 141-142():66-73. PubMed ID: 30935788 [TBL] [Abstract][Full Text] [Related]